Prokaryotics Scientific Advisory Board is made up of some of the world’s leading experts in the field of cell envelope biogenesis.

Thomas J. Silhavy, PhD

Dr. Silhavy is the Warner-Lambert Park-Davis Professor of Molecular Biology at Princeton University.  His area of expertise includes the bacterial genetics of Gram-negative cell envelope biogenesis.


Lynn Silver PhD

(Merck, LL Silver Consulting) - Recognized Thought Leader and Consultant in Antibacterial Discovery.


Richard Lee, PhD

(St. Jude Children’s Hospital) - Expert in Antibacterial Medicinal Chemistry and Structure-Based Design.


David Perlin, PhD

(Executive Director and professor, PHRI, New Jersey Medical School, Rutgers University) - Antibacterial in vitro and in vivo efficacy; mechanisms of drug resistance.


John Tomayko, MD

(GSK, Spero, Pfizer) - Infectious Disease Clinician and Clinical Development.


David Pompliano, PhD

(GSK, Merck, Lodo) - Infectious diseases drug discovery as former VP in big pharma, as entrepreneur at Third Rock Ventures, and as CSO at Revolution Medicines and Lodo Therapeutics.